Logo image of CNTG

CENTOGENE NV (CNTG) Stock Fundamental Analysis

USA - NASDAQ:CNTG - NL0014040206 - Common Stock

0.325 USD
-0.02 (-6.23%)
Last: 8/7/2024, 8:06:53 PM
0.351 USD
+0.03 (+8%)
After Hours: 8/7/2024, 8:06:53 PM
Fundamental Rating

1

Taking everything into account, CNTG scores 1 out of 10 in our fundamental rating. CNTG was compared to 100 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CNTG have multiple concerns. CNTG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CNTG has reported negative net income.
CNTG had a negative operating cash flow in the past year.
CNTG had negative earnings in each of the past 5 years.
CNTG had negative operating cash flow in 4 of the past 5 years.
CNTG Yearly Net Income VS EBIT VS OCF VS FCFCNTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

CNTG has a Return On Assets of -46.05%. This is amonst the worse of the industry: CNTG underperforms 85.34% of its industry peers.
Industry RankSector Rank
ROA -46.05%
ROE N/A
ROIC N/A
ROA(3y)-43.71%
ROA(5y)-32.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNTG Yearly ROA, ROE, ROICCNTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300 -400

1.3 Margins

Looking at the Gross Margin, with a value of 36.46%, CNTG is in the better half of the industry, outperforming 63.79% of the companies in the same industry.
CNTG's Gross Margin has declined in the last couple of years.
CNTG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.22%
GM growth 5Y-6.4%
CNTG Yearly Profit, Operating, Gross MarginsCNTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

CNTG does not have a ROIC to compare to the WACC, probably because it is not profitable.
CNTG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CNTG has been increased compared to 5 years ago.
The debt/assets ratio for CNTG is higher compared to a year ago.
CNTG Yearly Shares OutstandingCNTG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
CNTG Yearly Total Debt VS Total AssetsCNTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

CNTG has an Altman-Z score of -1.03. This is a bad value and indicates that CNTG is not financially healthy and even has some risk of bankruptcy.
CNTG has a worse Altman-Z score (-1.03) than 81.03% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC7.5%
CNTG Yearly LT Debt VS Equity VS FCFCNTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

CNTG has a Current Ratio of 1.02. This is a normal value and indicates that CNTG is financially healthy and should not expect problems in meeting its short term obligations.
CNTG has a worse Current ratio (1.02) than 68.10% of its industry peers.
CNTG has a Quick Ratio of 1.02. This is a bad value and indicates that CNTG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CNTG (0.96) is worse than 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.96
CNTG Yearly Current Assets VS Current LiabilitesCNTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

CNTG shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.92%.
The Revenue has been growing slightly by 2.25% in the past year.
The Revenue has been growing slightly by 3.70% on average over the past years.
EPS 1Y (TTM)-6.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.92%
Revenue 1Y (TTM)2.25%
Revenue growth 3Y8.07%
Revenue growth 5Y3.7%
Sales Q2Q%254.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y39.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNTG Yearly Revenue VS EstimatesCNTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CNTG Yearly EPS VS EstimatesCNTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNTG. In the last year negative earnings were reported.
Also next year CNTG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTG Price Earnings VS Forward Price EarningsCNTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNTG Per share dataCNTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CNTG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTOGENE NV

NASDAQ:CNTG (8/7/2024, 8:06:53 PM)

After market: 0.351 +0.03 (+8%)

0.325

-0.02 (-6.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-17 2024-06-17
Earnings (Next)09-04 2024-09-04
Inst Owners0.09%
Inst Owner Change-99.99%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.97M
Revenue(TTM)48.54M
Net Income(TTM)-35.53M
Analysts82.86
Price Target1.53 (370.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.39
EYN/A
EPS(NY)-1.09
Fwd EYN/A
FCF(TTM)-1.36
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS1.94
BVpS-1.01
TBVpS-1.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.05%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.46%
FCFM N/A
ROA(3y)-43.71%
ROA(5y)-32.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.22%
GM growth 5Y-6.4%
F-Score2
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.95%
Cap/Sales 4.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.96
Altman-Z -1.03
F-Score2
WACC7.5%
ROIC/WACCN/A
Cap/Depr(3y)25.62%
Cap/Depr(5y)60.29%
Cap/Sales(3y)7.53%
Cap/Sales(5y)16.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.92%
EPS Next Y39.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.25%
Revenue growth 3Y8.07%
Revenue growth 5Y3.7%
Sales Q2Q%254.74%
Revenue Next Year22.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.85%
OCF growth 3YN/A
OCF growth 5YN/A

CENTOGENE NV / CNTG FAQ

Can you provide the ChartMill fundamental rating for CENTOGENE NV?

ChartMill assigns a fundamental rating of 1 / 10 to CNTG.


What is the valuation status for CNTG stock?

ChartMill assigns a valuation rating of 0 / 10 to CENTOGENE NV (CNTG). This can be considered as Overvalued.


What is the profitability of CNTG stock?

CENTOGENE NV (CNTG) has a profitability rating of 1 / 10.


What is the expected EPS growth for CENTOGENE NV (CNTG) stock?

The Earnings per Share (EPS) of CENTOGENE NV (CNTG) is expected to grow by 39.38% in the next year.